NewJour is developed by Georgetown University Library, provides information about and access to online journals, magazines, and newsletters from around the world. NewJour is both a current awareness service and an archive of online publications. This service helps a journal to grow from a local level to a global one as well as providing complete web-based solution for small editorial teams.
Current Research into Cures for Type-1 Diabetes News and updates on potential cures for type-1 diabetes, that are in human or clinical trials.
Monday, October 29, Golimumab Update Golimumab sold as Simponi is an immune system modulator, which has been approved in the United States and many other countries for treatment of several autoimmune diseases, so testing it on type-1 diabetes makes a lot of sense.
Simponi has already been approved to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and ankylosing spondylitis. Golimumab is a monoclonal antibody, which is an artificially created antibody which targets one very specific molecule in the body.
If a disease is caused by that molecule or a cell marked by that moleculethen using a monoclonal antibody to target it is promising. There are three on-going clinical trials of Golimumab Simponi: Started Aug and expects to finish May fully enrolled in Aug Where: Started Oct and hopes to finish July Where: Started Aug and hopes to finish June Where: Benaroya Research Institute Summary I like this as a complete program.
These three studies cover Golimumab from many different points of view: Two of the studies are for children years old, and one for adults All are reasonable size.
The downside, is that we have to wait until to see results.
The good news is that bywe'll have results from three different studies to look at. First the autoimmune attack must be stopped, and second beta cells must be regrown.
By itself, such a treatment might cure presymptomatic or homeymoon type-1 because those people still have some beta cellsbut is unlikely to cure established typeInternational Journal of Unmanned Systems Engineering (IJUSEng) IJUSEng provides a refereed authoritative source of research in the field of unmanned systems engineering.
coordinates Microsoft’s Research in Software Engineering in Redmond, USA.
Our mission is to advance the state of the art in software engineering research and to bring those advances to Microsoft’s businesses. Visit the Microsoft Research career page.
For . Abstract. The ubiquity of frustrating, unhelpful software interfaces has motivated decades of research into “Human-Computer Interaction.” In this paper, I suggest that the long-standing focus on “interaction” may be misguided. Writing Good Software Engineering Research Papers Minitutorial Software engineering research answers questions What is the current state of X / practice of.
Research Topics in Software Engineering Be able to understand the latest developments Maybe research papers. International Journal of Engineering Research and Applications (IJERA) is a team of researchers not publication services or private publications running the journals for monetary benefits, we are association of scientists and academia who focus only on supporting authors who want to publish their work.